Thirdly, the outcome indicators included in this study are relatively comprehensive, covering both short-term and long-term postoperative IOP, BCVA, Incidence of postoperative hyphema, efficacy, Postoperative antiglaucoma medication requirements and aqueous humor VEGF levels. The gene discussed is VEGFA; the disease is Hyphema.